leflunomide has been researched along with Pneumoconiosis in 1 studies
Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.
Pneumoconiosis: A diffuse parenchymal lung disease caused by inhalation of dust and by tissue reaction to their presence. These inorganic, organic, particulate, or vaporized matters usually are inhaled by workers in their occupational environment, leading to the various forms (ASBESTOSIS; BYSSINOSIS; and others). Similar air pollution can also have deleterious effects on the general population.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Yasmine, M | 1 |
Kaouther, M | 1 |
Dhia, K | 1 |
Hanene, F | 1 |
Wafa, T | 1 |
Dorra, BN | 1 |
Wafa, H | 1 |
1 other study available for leflunomide and Pneumoconiosis
Article | Year |
---|---|
Treatment with Rituximab in Rheumatoid Pneumoconiosis: A Case Report.
Topics: Aged; Arthritis, Rheumatoid; Caplan Syndrome; Humans; Leflunomide; Male; Pneumoconiosis; Rituximab | 2023 |